Cargando…
Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
BACKGROUND: In childhood cancer, consolidation treatment with chemotherapy followed by autologous hematopoietic progenitor stem cell transplantation is currently an accepted treatment modality in patients with high-risk solid tumors or in patients who have relapsed after conventional treatment. OBJE...
Autores principales: | Vargas, Alberto Olaya, Luna, Roberto Rivera, Garcia, Martin Perez, Cardos, Rocio Cárdenas, Hidalgo, Liliana Velasco, Jácome, Doris LordMéndez, Gutiérrez, Mariana Campos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Hematologia e
Hemoterapia
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832315/ https://www.ncbi.nlm.nih.gov/pubmed/24255618 http://dx.doi.org/10.5581/1516-8484.20130099 |
Ejemplares similares
-
Comment on: Consolidation treatment for high risk solid tumors in
children with myeloablative chemotherapy and autologous hematopoietic progenitor stem
cell transplantation
por: Kletzel, Morris
Publicado: (2013) -
Triple-hit explanation for the worse prognosis of pediatric acute lymphoblastic leukemia among Mexican and Hispanic children
por: Rivera-Luna, Roberto, et al.
Publicado: (2022) -
Descriptive Epidemiology in Mexican children with cancer under an open national public health insurance program
por: Rivera-Luna, Roberto, et al.
Publicado: (2014) -
Autologous Hematopoietic Recovery after Unrelated Umbilical Cord Blood Transplantation with Myeloablative Conditioning for Acute Myelogenous Leukemia
por: Gomyo, Ayumi, et al.
Publicado: (2020) -
A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
por: Atilla, Erden, et al.
Publicado: (2017)